Dendritic-cell exosomes cross-present Toll-like receptor-ligands and activate bystander dendritic cells

Cellular Immunology

Volumn 289, Issue 1-2, 2014, Pages 119-127

  Sobo Vujanovic, Andrea ^a   Munich, Stephan ^c   Vujanovic, Nikola L ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b Department of Pathology ^*  (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dendritic cells; Exosomes; NK cells; Th1 response; TLR ligands; Transmembrane TNF

Indexed keywords

ANTINEOPLASTIC AGENT; CD14 ANTIGEN; DCEX; GAMMA INTERFERON; INTERLEUKIN 12P70; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; LIGAND; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CELL ACTIVATION; CELL FUNCTION; CELL INVASION; CONTROLLED STUDY; DENDRITIC CELL; DENDRITIC CELL EXOSOME; EFFECTOR CELL; EXOSOME; IMMUNE SYSTEM; IMMUNIZATION; INNATE IMMUNITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

DENDRITIC CELLS; EXOSOMES; NK CELLS; TH1 RESPONSE; TLR LIGANDS; TRANSMEMBRANE TNF;

ANIMALS; ANTIGEN PRESENTATION; BACTERIAL OUTER MEMBRANE PROTEINS; BYSTANDER EFFECT; DENDRITIC CELLS; EXOSOMES; FEMALE; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LIPOPEPTIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MICE, SCID; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899100763     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.03.016     Document Type: Article

References (25)

1. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
2. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nature Reviews Immunology 2003, 3:984-993.
3. Trinchieri G., Sher A. Cooperation of Toll-like receptor signals in innate immune defense. Nature Reviews Immunology 2007, 7:179-190.
4. Lu G., Janjic B.M., Janic J., Whiteside T.L., Storkus W.J., Vujanovic N.L. Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, LT-α1β2, FasL and TRAIL. J. Immunol. 2002, 168:1831-1839.
5. Janjic B.M., Lu G., Pimenov A., Whiteside T.L., Storkus W.J., Vujanovic N.L. Innate direct anticancer effector function of human immature dendritic cells. I. Involvement of an apoptosis-inducing pathway. J. Immunol. 2002, 168:1823-1830.
6. Vujanovic N.L. Role of TNF superfamily ligands in innate immunity. Immunologic Research 2011, 50:159-174.
7. Becknell B., Caligiuri M.A. Natural killer cells in innate immunity and cancer. Journal of Immunotherapy 1989, 31:685-692.
8. Moretta A., Marcenaro E., Sivori S., Chiesa M.D., Vitale M., Moretta L. Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends in Immunology 2005, 26:668-675.
9. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nature Reviews Immunology 2002, 2:957-964.
10. Xu J., Chakrabarti A.K., Tan J.A., Ge L., Gambotto A., Vujanovic N.L. Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell-natural killer cell cross-talk. Blood 2007, 109:3333-3341.
11. Vujanovic L., Szymkowski D.E., Vujanovic N.L., Butterfield L.H. Virally-infected and cytokine-matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15. Blood 2010, 116:575-583.
12. Fevrier B., Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Current Opinion in Cell Biology 2004, 16:415-421.
13. Stoorvogel W., Kleijmeer M.J., Geuze H.J., Raposo G. The biogenesis and function of exosomes. Traffic 2002, 3:321-330.
14. Chaput N., Flament C., Vlaud S., Taie J., Roux S., Spatz A., André F., LePecq J.B., Boussac M., Garin J., Amigorena S., Théry C., Zitvogel L. Dendritic cell derived exosomes: biology and clinical implementations. Journal of Leukocyte Biology 2006, 80:471-478.
15. Morelli A.E., Larregina A.T., Shufesky W.J., Sullivan M.L.G., Beer-Stolz D., Papworth G.D., Zahorchak A.F., Logar A.J., Wang Z., Watkins S.C., Falo L.D., Thomson A.W. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 2004, 104:3257-3266.
16. Zitvogel L., Regnault A., Lozier A., Wolfers J., Flament C., Tenza D., Ricciardi-Castagnoli P., Raposo G., Amigorena S. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nature Medicine 1998, 4:594-600.
17. Therry C., Duban L., Segura E., Veron P., Lantz O., Amigorena S. Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes. Nature Immunology 2002, 3:1156-1162.
18. Chaput N., Andre F., Schartz N.E., Flament C., Angevin E., Escudier B., Zitvogel L. Exosomes and anti-tumor immunotherapy. Bulletin du Cancer 2003, 90:695-698.
19. Viaud S., Thery C., Ploix S., Tursz T., Lapierre V., Lantz O., Zitvogel L., Chaput N. Dendritic cell-derived exosomes for cancer immunotherapy: what's next. Cancer Research 2010, 70:1281-1285.
20. Munich S., Sobo-Vujanovic A., Buchser W.J., Beer-Stolz D., Vujanovic N.L. Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands. OncoImmunology 2012, 1:1074-1083.
21. Zalevsky J., Secher T., Ezhevsky S.A., Janot L., Steed P.M., O'Brien C., Eivazi A., Kung J., Nguyen D.H.T., Doberstein S.K., Erard F., Ryffel B., Szymkowski D.E. Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection. J. Immunol. 2007, 179:1872-1883.
22. Habich C., Kempe K., van der Zee R., Rumenapf R., Akiyama H., Kolb H., Burkart V. Heat shock protein 60: specific binding of lipopolysaccharide. J. Immunol. 2005, 174:1298-1305.
23. Couturier C., Haeffner-Cavaillon N., Caroff M., Kazatchkine M.D. Binding sites for endotoxins (lipopolysaccharides) on human monocytes. J. Immunol. 1991, 147:1899-1904.
24. Bhatnagar S., Schorey J.S. Exosomes released from infected macrophages contain Mycobacterium avium glycopeptidolipids and are proinflammatory. Journal of Biological Chemistry 2007, 282:25779-25789.
25. Bhatnagar S., Shinagawa K., Castellino F.J., Schorey J.S. Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood 2007, 110:3234-3244.